$21.14
+
$0.32 (1.54%)
End-of-day quote: 05/14/2024
NasdaqGM:SLN
Silence Therapeutics Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| GWPH | GW Pharmaceuticals | NasdaqGM | - | $219.00 | $188.33 | 0.00% | 0 | $6.91B |
| ABCM | Abcam | NasdaqGS | - | $23.99 | $19.25 | 0.00% | 0 | $5.52B |
| GNS | Genus | LSE | Buy | £18.60 | £33.09 | 0.00% | 2 | £1.18B |
| AUTL | Autolus Therapeutics | NasdaqGS | Buy | $3.93 | $9.23 | 0.00% | 1 | $1.05B |
| BCYC | Bicycle Therapeutics | NasdaqGS | Outperform | $21.85 | $44.47 | 0.00% | 11 | $1.05B |
| CMPS | COMPASS Pathways | NasdaqGS | Buy | $8.17 | $45.43 | 0.00% | 3 | $537.17M |
| MREO | Mereo BioPharma Group | NasdaqCM | Buy | $2.96 | $3.46 | 0.00% | 1 | $427.07M |
| ORTX | Orchard Therapeutics | NasdaqCM | - | $16.70 | $16.00 | 0.00% | 0 | $380.12M |
| NIOX | NIOX Group Plc | AIM | Buy | £0.74 | £0.76 | 0.00% | 0 | £301.02M |
| OXB | Oxford Biomedica | LSE | Outperform | £3.20 | £4.24 | 0.00% | 2 | £276.50M |
| ADAP | Adaptimmune Therapeutics | NasdaqGS | Outperform | $1.15 | $3.60 | 0.00% | 0 | $286.23M |
| BVXP | Bioventix PLC | AIM | £43.75 | £44.00 | 0.00% | 1 | £223.14M | |
| HZD | Horizon Discovery Group | AIM | - | £0.00 | £0.00 | 0.00% | 0 | £161.93M |
| ETX | e-therapeutics | AIM | £0.16 | £0.16 | 0.00% | 0 | £133.27M | |
| AGY | Allergy Therapeutics | AIM | - | £0.03 | £0.50 | 0.00% | 0 | £119.16M |
| SCLP | Scancell Holdings | AIM | Buy | £0.10 | £0.23 | 0.00% | 1 | £79.52M |
| BRNS | Barinthus Biotherapeutics | NasdaqGM | Outperform | $2.32 | $8.80 | 0.00% | 0 | $90.88M |
| REDX | Redx Pharma Plc | AIM | - | £0.17 | £1.25 | 0.00% | 0 | £71.96M |
| NANO | Nanoco Group | LSE | £0.18 | £0.09 | 0.00% | 0 | £63.70M | |
| DNL | Diurnal Group | AIM | - | £0.27 | £0.69 | 0.00% | 0 | £45.66M |
| TLSA | Tiziana Life Sciences Ltd | NasdaqCM | Buy | $0.52 | $5.00 | 0.00% | 0 | $56.83M |
| TRX | Tissue Regenix Group | AIM | £0.62 | £1.20 | 0.00% | 0 | £43.30M | |
| OKYO | OKYO Pharma | NasdaqCM | Outperform | $1.51 | $4.00 | 0.00% | 0 | $46.87M |
| APM | Aptorum Group | NasdaqCM | - | $4.60 | $150.00 | 0.00% | 0 | $28.72M |
| HEMO | Hemogenyx Pharmaceuticals Plc | LSE | - | £0.02 | £0.00 | 0.00% | 0 | £22.14M |
| OPTI | OptiBiotix Health Plc | AIM | - | £0.24 | £0.00 | 0.00% | 0 | £18.05M |
| IMM | ImmuPharma | AIM | - | £0.01 | £0.03 | 0.00% | 0 | £16.79M |
| DEST | Destiny Pharma | AIM | Buy | £0.16 | £2.10 | 0.00% | 1 | £15.96M |
| COS | Collagen Solutions | AIM | - | £0.00 | £0.21 | 0.00% | 0 | £13.75M |
| SNG | Synairgen | AIM | Hold | £0.06 | £0.40 | 0.00% | 0 | £13.33M |
| OBD | Oxford BioDynamics Plc | AIM | £0.14 | £0.00 | 0.00% | 0 | £12.79M | |
| NCNA | NuCana | NasdaqCM | Buy | $3.88 | $4.44 | 0.00% | 1 | $12.39M |
| BDRX | Biodexa Pharmaceuticals Plc | NasdaqCM | - | $1.72 | $13.40 | 0.00% | 0 | $10.83M |
| GDR | genedrive | AIM | - | £0.02 | £0.85 | 0.00% | 0 | £8.41M |
| AKTX | Akari Therapeutics, Plc | NasdaqCM | - | $1.50 | $80.00 | 0.00% | 0 | $9.39M |
| VAL | ValiRx | AIM | £0.03 | £164.06 | 0.00% | 0 | £4.43M | |
| EVG | Evgen Pharma | AIM | £0.01 | £0.22 | 0.00% | 0 | £3.31M | |
| RENE | ReNeuron Group | AIM | £0.03 | £0.55 | 0.00% | 1 | £1.93M | |
| PYC | Physiomics Plc | AIM | £0.01 | £0.20 | 0.00% | 0 | £1.90M | |
| MTFB | Motif Bio | AIM | - | 0.00 | 0.00 | 0.00% | 0 | 3.27M |
